$NASDAQ:RLAY

Relay Therapeutics Intrinsic Value Calculation – RELAY THERAPEUTICS Insider Share Sales Raise Concerns for Investors
Gallery

Relay Therapeutics Intrinsic Value Calculation – RELAY THERAPEUTICS Insider Share Sales Raise Concerns for Investors

☀️Trending News RELAY THERAPEUTICS ($NASDAQ:RLAY), a biotechnology company focused on developing precision medicines for patients with genetically defined diseases, has [...]

By GoodWhale|November 3, 2024|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

Relay Therapeutics Intrinsic Stock Value – Relay Therapeutics, Poised to Beat Earnings Estimates: Is It Time to Buy?
Gallery

Relay Therapeutics Intrinsic Stock Value – Relay Therapeutics, Poised to Beat Earnings Estimates: Is It Time to Buy?

☀️Trending News Relay Therapeutics ($NASDAQ:RLAY), Inc. is poised to beat earnings estimates and investors are asking if it is the [...]

By GoodWhale|October 31, 2023|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

RELAY THERAPEUTICS Reports Second Quarter Fiscal Year 2023 Earnings Results on August 8 2023
Gallery

RELAY THERAPEUTICS Reports Second Quarter Fiscal Year 2023 Earnings Results on August 8 2023

🌥️Earnings Overview RELAY THERAPEUTICS ($NASDAQ:RLAY) announced their financial results for the second quarter of 2023, ending June 30, on August [...]

By GoodWhale|August 13, 2023|Categories: Biotechnology, Earnings Report|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

Relay Therapeutics Stocks Reach New Highs Despite 0.25% Dip in Trading Session
Gallery

Relay Therapeutics Stocks Reach New Highs Despite 0.25% Dip in Trading Session

🌥️Trending News The company focuses on developing innovative medicines targeting protein conformations to treat a variety of diseases, particularly cancer [...]

By GoodWhale|June 30, 2023|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

HC Wainwright Lowers Relay Therapeutics’ Price Target to $32.00
Gallery

HC Wainwright Lowers Relay Therapeutics’ Price Target to $32.00

🌧️Trending News HC Wainwright has recently lowered the price target for Relay Therapeutics ($NASDAQ:RLAY) to $32.00, as reported by Defense [...]

By GoodWhale|June 25, 2023|Categories: Biotechnology, Market Price|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

Relay Therapeutics Sees -1.96% Loss Despite Investors’ Interest
Gallery

Relay Therapeutics Sees -1.96% Loss Despite Investors’ Interest

🌧️Trending News Relay Therapeutics ($NASDAQ:RLAY) Inc. is a biopharmaceutical company focused on developing therapeutics to treat diseases related to cancer [...]

By GoodWhale|June 21, 2023|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

Relay Therapeutics Achieves Positive Results in Solid Tumor Dose Escalation Phase 1/2 Study
Gallery

Relay Therapeutics Achieves Positive Results in Solid Tumor Dose Escalation Phase 1/2 Study

Trending News ☀️ Relay Therapeutics ($NASDAQ:RLAY), a biopharmaceutical company focused on creating medicines that target protein motions associated with diseases, [...]

By GoodWhale|May 26, 2023|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

Relay Therapeutics’ Revenue Beats Expectations, but Earnings Miss Mark
Gallery

Relay Therapeutics’ Revenue Beats Expectations, but Earnings Miss Mark

Trending News 🌧️ Relay Therapeutics ($NASDAQ:RLAY), a biotechnology company specializing in research and development of medicines for cancer and other [...]

By GoodWhale|May 6, 2023|Categories: Biotechnology|Tags: $NASDAQ:RLAY, Biotechnology, NASDAQ|0 Comments

RELAY THERAPEUTICS Shares Plunge Following Release of RLY-2608 Cancer Drug Data
Gallery

RELAY THERAPEUTICS Shares Plunge Following Release of RLY-2608 Cancer Drug Data

Trending News 🌧️ Shares of Relay Therapeutics ($NASDAQ:RLAY), a biopharmaceutical company focused on the development of medicines to treat cancer, [...]